Laura & Isaac Perlmutter Cancer Center at NYU Langone Health — New York, New York

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health has participated in 41 clinical trials with 28 currently active.

Therapeutic areas: NSCLC, Urinary Bladder Neoplasms, Carcinoma in Situ.

Sponsors: Eikon Therapeutics, Astellas Pharma Global Development, Inc., Nested Therapeutics, Inc.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laura & Isaac Perlmutter Cancer Center at NYU Langone Health?

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laura & Isaac Perlmutter Cancer Center at NYU Langone Health conducted?

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health has 41 clinical trials on record, with 28 currently active. Their work covers NSCLC, Urinary Bladder Neoplasms, Carcinoma in Situ.

Is Laura & Isaac Perlmutter Cancer Center at NYU Langone Health accredited by Crixeo Health?

Yes — Laura & Isaac Perlmutter Cancer Center at NYU Langone Health holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Laura & Isaac Perlmutter Cancer Center at NYU Langone Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.